Drug intelligence / Profile preview

Yuandu Cold Granule

Development stage: Unknown
Lead developer: Shandong Wohua Pharmaceutical
Administration: Oral

Overview

Yuandu Cold Granule (鸢都感冒颗粒) is a traditional Chinese medicine (TCM) granule developed and marketed by Shandong Wohua Pharmaceutical Co., Ltd. It is specifically indicated for the treatment of the common cold and influenza, particularly those classified as "wind-heat" type according to TCM diagnostic principles. As a TCM formulation, it is composed of a proprietary blend of herbal ingredients designed to clear heat and resolve toxins. The product is administered orally and is an approved pharmaceutical product in China.

Brand names: Yuandu Cold Granule鸢都感冒颗粒
Other names: Yuandu Ganmao KeliYuandu Ganmao granules

Beyond the preview

Go deeper on Yuandu Cold Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuandu Cold Granule.

Explore the full profile